Adaptation of the behaviour of an aspartic proteinase inhibitor by relocation of a lysine residue by one helical turn

Abstract In addition to self-inhibition of aspartic proteinase zymogens by their intrinsic proparts, the activity of certain members of this enzyme family can be modulated through active-site occupation by extrinsic polypeptides such as the small IA3 protein from Saccharomyces cerevisiae. The unprecedented mechanism by which IA3 helicates to inhibit its sole target aspartic proteinase locates an i, i+4 pair of charged residues (Lys18+Asp22) on an otherwise-hydrophobic face of the amphipathic helix. The nature of these residues is not crucial for effective inhibition, but re-location of the lysine residue by one turn (+4 residues) in the helical IA3 positions its side chain in the mutant IA3-proteinase complex in an orientation essentially identical to that of the key lysine residue in zymogen proparts. The binding of the extrinsic mutant IA3 shows pH dependence reminiscent of that required for the release of intrinsic zymogen proparts so that activation can occur.

[1]  B. Dunn Structure and mechanism of the pepsin-like family of aspartic peptidases. , 2002, Chemical reviews.

[2]  Leif Smith,et al.  IA3, an aspartic proteinase inhibitor from Saccharomyces cerevisiae, is intrinsically unstructured in solution. , 2004, Biochemistry.

[3]  F. Winkler,et al.  Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases? , 1999, Chemistry & biology.

[4]  Alexander Wlodawer,et al.  The Potency and Specificity of the Interaction between the IA3 Inhibitor and Its Target Aspartic Proteinase fromSaccharomyces cerevisiae * , 2001, The Journal of Biological Chemistry.

[5]  A. R. Khan,et al.  Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes , 1998, Protein science : a publication of the Protein Society.

[6]  Alice Stanton,et al.  Structure-based design of aliskiren, a novel orally effective renin inhibitor. , 2003, Biochemical and biophysical research communications.

[7]  John W. Erickson,et al.  Conformational switching in an aspartic proteinase , 1998, Nature Structural Biology.

[8]  Chi-Huey Wong,et al.  HIV‐1 Protease: Mechanism and Drug Discovery , 2003 .

[9]  J. Kay,et al.  An aspartic proteinase gene family in the filamentous fungus Botrytis cinerea contains members with novel features. , 2004, Microbiology.

[10]  J. Kay,et al.  Autoprocessing and Peptide Substrates for Human Herpesvirus 6 Proteinase* , 1998, The Journal of Biological Chemistry.

[11]  Alexander Wlodawer,et al.  The aspartic proteinase from Saccharomyces cerevisiae folds its own inhibitor into a helix , 2000, Nature Structural Biology.

[12]  Corinne Antignac,et al.  Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis , 2005, Nature Genetics.

[13]  M. James,et al.  Crystal and molecular structures of human progastricsin at 1.62 A resolution. , 1995, Journal of molecular biology.

[14]  Robert G. Ridley,et al.  Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from Plasmodium falciparum , 1999, Nature Structural Biology.

[15]  M. James,et al.  Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3   , 2000, Nature Structural Biology.